Biomedcode is a Contract Research Organisation (CRO) providing full preclinical drug evaluation services to the pharmaceutical industry using a unique collection of proprietary mouse models of human inflammatory diseases. With a primary focus on anti-TNF therapeutics, Biomedcode’s Tg197 humanized animal model of Rheumatoid Arthritis was instrumental in demonstrating the therapeutic efficacy of Infiximab (Remicade®) currently one of the most successful anti-TNF therapeutics.